Barclays Forecasts Strong Price Appreciation for CME Group (NASDAQ:CME) Stock

CME Group (NASDAQ:CME) had its price objective lifted by equities researchers at Barclays from $312.00 to $344.00 in a research report issued on Wednesday, MarketBeat.com reports. The firm currently has an “equal weight” rating on the financial services provider’s stock. Barclays‘s target price would indicate a potential upside of 15.08% from the company’s current price.

Several other research firms have also issued reports on CME. Jefferies Financial Group raised their price target on shares of CME Group from $302.00 to $356.00 and gave the stock a “buy” rating in a research report on Monday, March 2nd. Keefe, Bruyette & Woods started coverage on shares of CME Group in a research report on Wednesday. They issued a “market perform” rating and a $305.00 price target on the stock. Bank of America raised their price target on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Morgan Stanley raised their price target on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, TD Cowen raised their price target on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $307.88.

CME Group Price Performance

Shares of CME Group stock opened at $298.93 on Wednesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.03. The company has a market cap of $107.20 billion, a PE ratio of 26.79, a price-to-earnings-growth ratio of 2.96 and a beta of 0.26. The firm has a fifty day moving average price of $306.24 and a two-hundred day moving average price of $284.16. CME Group has a fifty-two week low of $251.90 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period last year, the business posted $2.52 EPS. Analysts expect that CME Group will post 10.49 EPS for the current year.

Insider Buying and Selling at CME Group

In other news, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the sale, the director directly owned 24,999 shares in the company, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the sale, the director owned 43,007 shares in the company, valued at approximately $13,317,117.55. This trade represents a 8.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 8,539 shares of company stock valued at $2,713,821 in the last 90 days. Insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

Several institutional investors have recently made changes to their positions in CME. Caldwell Trust Co boosted its position in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after buying an additional 50 shares in the last quarter. Asset Dedication LLC boosted its position in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in CME Group in the third quarter valued at about $27,000. FNY Investment Advisers LLC acquired a new position in CME Group in the fourth quarter valued at about $27,000. Finally, Elkhorn Partners Limited Partnership acquired a new position in CME Group in the fourth quarter valued at about $27,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record international volumes: CME reported Q1 international average daily volume of 11.4 million contracts, up ~30% YoY, with all major regions and many product classes at all-time highs — a clear revenue tailwind from elevated client activity. PR Newswire: Q1 ADV
• Positive Sentiment: Crypto product expansion: CME confirmed launches of regulated futures for SUI (and Avalanche), giving institutional clients 24/7 derivatives access to these tokens — a new revenue stream and liquidity moat for CME’s crypto franchise. Blockonomi: SUI futures launch
• Positive Sentiment: Analyst bullish moves: TD Cowen and Barclays raised price targets this week (TD Cowen to $340, Barclays to $344), reflecting confidence in volume/earnings resilience — supportive for medium-term sentiment. TD Cowen note Barclays note
• Neutral Sentiment: Mixed broker coverage and expectations: New coverage and consensus remains around a “moderate buy” / market‑perform mix (Keefe, Raymond James, American Banking News), so analyst views are constructive but varied. AmericanBankingNews: consensus
• Neutral Sentiment: Product usage signal: CME’s market tools (e.g., Fed‑rate odds) showed material shifts after geopolitical headlines, highlighting the firm’s central role in price discovery but not directly changing fundamentals. CNBC: Fed odds
• Negative Sentiment: Regulatory/political scrutiny after large, time‑sensitive oil trades: The White House issued an ethics warning after reports of ~$760M in oil futures traded minutes before a cease‑fire announcement and sizeable profits in prediction markets — this raises reputational and potential regulatory risk because CME operates WTI futures traded in those blocks. Quiver: White House ethics warning
• Negative Sentiment: Large block oil bets add headline risk: Separate reporting of an approximately $950M bearish oil futures block placed hours before a cease‑fire announcement underscores scrutiny of large, pre‑announcement trades and can drive volatile flows and political attention. Quiver: $950M oil bet
• Negative Sentiment: Minor analyst trim: Jefferies cut its price target slightly (356→349) while keeping a buy rating — a modest near‑term sentiment headwind. MarketScreener: Jefferies PT cut

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.